Andrea S. Blevins Primeau, PhD, MBA

Immune checkpoint inhibitor treatment may increase the risk of tuberculosis reactivation or latent tuberculosis infection in patients with cancer.

Researchers sought to determine whether adding sorafenib to chemotherapy would improve survival in patients with FLT3-ITD AML.

The prevalence of substance use disorder in cancer survivors varies by cancer type, a large study suggests.

Treatment de-escalation was not effective in patients with previously untreated, metastatic colorectal cancer in the phase 3 ERMES study.

Researchers have identified disparities in cancer research funding from the National Cancer Institute and nonprofit organizations.

CD5-directed CAR-T cells can produce responses in patients with relapsed or refractory T-cell lymphoma, data suggest.

Differences in exposure to industrial emissions of carcinogens may help explain cancer disparities, according to researchers.

Stereotactic ablative radiotherapy has demonstrated safety and efficacy in patients with oligometastatic soft tissue sarcoma, according to researchers.

Adding serplulimab to first-line chemotherapy improved survival outcomes in a phase 3 trial of patients with advanced NSCLC.

Patients with operable gastric cancer may have different outcomes according to sex.